Thioredoxin reductase 2 (TXNRD2) mutation associated with familial glucocorticoid deficiency (FGD)

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 8, 2014, Pages

  Prasad, Rathi ^a   Chan, Li F ^a   Hughes, Claire R ^a   Kaski, Juan P ^b   Kowalczyk, Julia C ^a   Savage, Martin O ^a   Peters, Catherine J ^b   Nathwani, Nisha ^c   Clark, Adrian J L ^a   Storr, Helen L ^a   Metherell, Louise A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c LUTON AND DUNSTABLE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADRENAL INSUFFICIENCY; ADULT; ANIMALS; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; CONSANGUINITY; FEMALE; HOMOZYGOTE; HUMANS; MALE; MICE; MUTATION; PEDIGREE; STEROID METABOLISM, INBORN ERRORS; THIOREDOXIN REDUCTASE 2;

EID: 84905819540     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3844     Document Type: Article

References (24)

1. Meimaridou E, Hughes CR, Kowalczyk J, et al. Familial glucocorticoid deficiency: new genes and mechanisms. Mol Cell Endocrinol. 2013;371:195-200.
2. Clark AJ, McLoughlin L, Grossman A. Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor. Lancet. 1993;341:461-462.
3. Metherell LA, Chapple JP, Cooray S, et al. Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, causes familial glucocorticoid deficiency type 2. Nat Genet. 2005;37:166-170.
4. Hughes CR, Guasti L, Meimaridou E, et al.MCM4mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans. J Clin Invest. 2012;122:814-820.
5. Meimaridou E, Kowalczyk J, Guasti L, et al. Mutations in NNT encoding nicotinamide nucleotide transhydrogenase cause familial glucocorticoid deficiency. Nat Genet. 2012;44:740-742.
6. Darrah PA, Patel DT, De Luca PM, et al. Multifunctional TH1 cells define a correlate of vaccine mediated protection against Leishmania major. Nat Med. 2007;13:843-850.
7. Biterova El, Turanov AA, Gladyshev VN, Barycki JJ. Crystal structures of oxidised and reduced mitochondrial thioredoxin reductase provide molecular details of the reaction mechanism. Proc Natl Acad Sci USA. 2005;102:15018-15023.
8. Kil IS, Lee SK, Ryu KW, et al. Feedback control of adrenal steroidogenesis via H2O2-dependent, reversible inactivation of peroxiredoxin III in mitochondria. Mol Cell. 2012;46:584-594.
9. Godoy JR, Funke M, Ackermann W, et al. Redox atlas of the mouse. Immunohistochemical detection of glutaredoxin-, peroxiredoxin-, and thioredoxin-family proteins in various tissues of the laboratory mouse. Biochim Biophys Acta. 2011;1810:2-92.
10. Kryukov GV, Castellano S, Novoselov SV, et al. Characterization of mammalian selenoproteomes. Science. 2003;300:1439-1443.
11. Hanschmann EM, Lönn ME, Schütte LD, et al. Both thioredoxin 2 and glutaredoxin 2 contribute to the reduction of the mitochondrial 2-Cys peroxiredoxin Prx3. J Biol Chem. 2010;285:40699-40705.
12. Zhang H, Go YM, Jones DP. Mitochondrial thioredoxin-2/peroxiredoxin- 3 system functions in parallel with mitochondrial GSH system in protection against oxidative stress. Arch Biochem Biophys. 2007;465:119-126.
13. Diemer T, Allen JA, Hales KH, Hales DB. Reactive oxygen disrupts mitochondria in MA-10 tumor Leydig cells and inhibits steroidogenic acute regulatory (StAR) protein and steroidogenesis. Endocrinology. 2003;144:2882-2891.
14. Hanukoglu I. Antioxidant protective mechanisms against reactive oxygen species (ROS) generated by mitochondrial P450 systems in steroidogenic cells. Drug Metab Rev. 2006;38:171-196.
15. Hirano M, Furiya Y, Asai H, Yasui A, Ueno S. ALADIN1482S causes selective failure of nuclear protein import and hypersensitivity to oxidative stress on triple A syndrome. Proc Natl Acad Sci USA. 2006;103:2298-2303.
16. Storr HL, Kind B, Parfitt DA, et al. Deficiency of ferritin heavy-chain nuclear import in triple A syndrome implies nuclear oxidative damage as the primary disease mechanism. Mol Endocrinol. 2009;12: 2086-2094.
17. Kemp S, Berger J, Aubourg P. X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects. Biochim Biophys Acta. 2012;1822:1465-1474.
18. Conrad M, Jakupoglu C, Moreno SG, et al. Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function. Mol Cell Biol. 2004;24:9414-9423.
19. Sibbing D, Pfeufer A, Perisic T, et al. Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy. Eur Heart J. 2011;32:1121-1133.
20. MommaK. Cardiovascular anomalies associated with chromosome 22q11.2 deletion syndrome. Am J Cardiol. 2010;105:1617-1624.
21. Yagi H, Furutani Y, Hamada H, et al. Role of TBX1 in human del22q11.2 syndrome. Lancet. 2003;362:1366-1373.
22. Moon AM, Guris DL, Seo JH, et al. Crkl deficiency disrupts Fgf8 signaling in a mouse model of 22q11 deletion syndromes. Dev Cell. 2006;10:71-80.
23. Rajamohan SB, Raghuraman G, Prabhakar NR, Kumar GK. NADPH oxidase-derived H2O2 contributes to angiotensin II-induced aldosterone synthesis in human and rat adrenal cortical cells. Antoxid Redox. 2012;17:445-459.
24. Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev. 2011;32:81-151.